MABVAX THERAPEUTICS HOLDINGS, INC. — Form D

MABVAX THERAPEUTICS HOLDINGS, INC. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-04-09. The offering totals $15.0M, of which $11.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Gregory HansonDirectorSan Diego, CA
Robert HoffmanDirectorHouston, TX
Jeffrey RavetchDirectorSan Diego, CA
Thomas VarranoDirectorSan Diego, CA
Paul ResnickExecutive OfficerLexington, MA
Jeffrey EisenbergDirectorFramingham, MA
Paul V MaierDirectorDeer Park, IL
Paul MaierDirectorEL CAJON, CA
THOMAS VARVARODirectorIRVINE, CA
Thomas C VarvaroDirectorSan Diego, CA
J. David HansenDirectorSan Diego, CA
J. David HansenExecutive OfficerSan Diego, CA
Philip O LivingstonDirectorSan Diego, CA
Philip O LivingstonExecutive OfficerSan Diego, CA
Gregory P HansonExecutive OfficerSan Diego, CA
Paul W ResnickExecutive OfficerSan Diego, CA
Jeffrey F EisenbergDirectorSan Diego, CA
Paul W MaffuidExecutive OfficerSan Diego, CA
Philip LivingstonDirectorSan Diego, CA
Kenneth CohenDirectorSan Diego, CA
Gregory HansonExecutive OfficerSan Diego, CA
Paul MaffuidExecutive OfficerSan Diego, CA
Jeffrey V RavetchDirectorSan Diego, CA
J. David HansenDirectorSan Diego, CA
J. David HansenExecutive OfficerSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2018-05-15D$860K$830K
2018-02-13D$2.8M$2.8M
2014-07-10D$5.2M$5.2M
2014-05-22D$4.6M$4.6M

More